Amanda Adler
Professor of Diabetic Medicine and Health Policy
- Director of Diabetes Trials Unit
Recent publications
-
NICE guidance on caplacizumab for treating acute acquired thrombotic thrombocytopenia purpura.
Journal article
Hughes M. et al, (2021), Lancet Haematol, 8, e14 - e15
-
Impact of a Global Pandemic on Health Technology Assessment.
Journal article
Lorgelly PK. and Adler A., (2020), Appl Health Econ Health Policy, 18, 339 - 343
-
Cannabidiol with clobazam for seizures associated with Dravet and Lennox-Gastaut syndromes
Journal article
Lamb A. et al, (2020), The Lancet Neurology, 19, 290 - 291
-
NICE guidance on sotagliflozin for type 1 diabetes.
Journal article
Adler AI. et al, (2020), Lancet Diabetes Endocrinol, 8, 274 - 275
-
To treat or not to treat: dysglycaemia in cystic fibrosis.
Journal article
Adler AI., (2019), Diabetic medicine : a journal of the British Diabetic Association, 36, 1365 - 1366